The Vitruvian Man by Leonardo DaVinci may need a half-millenium update when considering the latest developments in the field of synthetic biology and the inescapable modern-day overlap with cybersecurity and data privacy laws.

What comes next can only be described as maybe incredible for an emerging vanguard industry that should look to the partial evolutionary arc of cybersecurity and data protection in other industries, like healthcare and finance, to avoid getting mired in indecision and lack of readiness.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]